Driving reinvestment in R&D for antibiotics and advocating their responsible use


BEAM Alliance is DRIVE-AB’s newest Associate Partner

The European Beam Alliance is DRIVE-AB's newest Associate Partner. The group of small and medium sized European biopharmaceutical companies are involved in innovation in the field of antimicrobial resistance research and work to improve the regulatory, investment, and commercial environments in Europe for research, development, approval and market viability of new products combating antimicrobial resistance. The Beam Alliance will support DRIVE-AB in our work to develop new reward models to drive investment in antibiotic discovery and development activities.  ...
Read more

IDSA Releases New Antibiotic Stewardship Guidelines with Focus on Practical Advice for Implementation

The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) have developed and published new guidelines on antibiotic stewardship in the journal Clinical Infectious Diseases. Preauthorization of broad-spectrum antibiotics and prospective review after two or three days of treatment should form the cornerstone of antibiotic stewardship programs to ensure the right drug is prescribed at the right time for the right diagnosis. These are among the numerous recommendations included in new guidelines released by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) and published...
Read more

George Osborne tells us Antibiotic Resistance is on track to be a greater threat to our health than cancer

George Osborne warned delegates at the International Monetary Fund (IMF) in Washington, DC, on 14 April 2016 that antibiotic resistance will become “an even greater threat to mankind than cancer” if the world fails to take action. The Chancellor said that according to evidence from the UK’s Review on Antimicrobial Resistance, antibiotic resistance could claim 10 million lives worldwide by the year 2050 if we, as a global society, fail to act.   Click here to read the full article.    ...
Read more

DRIVE-AB Progress and “Responsible Use of Antibiotics” Preliminary Findings Featured at ECCMID 2016

The DRIVE-AB consortium had a significant presence at this year's European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) 2016 in Amsterdam, being featured at the European Network Corner, the Pipeline Corner and Pipeline Talk, and presenting a numerous abstracts. The consortium presented a poster in the European Network Corner on DRIVE-AB's progress to date. Please click here to see the overview of the project's midterm progress. DRIVE-AB Work Package 1A, ‘Responsible use of antibiotics, new and old’, presented preliminary results at the Congress; one oral presentation and four posters (details below) on quality and...
Read more